The invention concerns pharmaceutical preparations that are stable on storage, which contain at least one diphosphonic acid and/or at least one physiologically acceptable salt of such an acid as the active substance.
The present invention concerns a storage-stable, aqueous solution of 4-[2-(benzenesulphonylamino)-ethyl]-phenoxyacetic acid for pharmaceutical purposes.